marks published for opposition - U.S. Patent and Trademark Office

TM 470 OFFICIAL GAZETTE JULY 17, 2012
CLASS 5—(Continued).
SN 79-104,712. BIOFARMA, FRANCE, FILED 1-24-2011.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF INTERNATIONAL REGISTRATION 0730750
DATED 3-17-2000, EXPIRES 3-17-2020.
OWNER OF U.S. REG. NO. 3,000,953.
THE WORDING "DOMANIR" HAS NO MEANING IN A
FOREIGN LANGUAGE.
FOR PHARMACEUTICAL PREPARATIONS FOR THE
PREVENTION AND TREATMENT OF CENTRAL NER-
VOUS SYSTEM DISEASES, ANTIDEPRESSANTS; PHAR-
MACEUTICAL PREPARATIONS FOR THE
PREVENTION AND TREATMENT OF ALZHEIMER’S
DISEASE; PHARMACEUTICAL PREPARATIONS FOR
THE PREVENTION AND TREATMENT OF PARKIN-
SON’S DISEASE; ANTIDIABETIC PHARMACEUTICAL
PREPARATIONS (U.S. CLS. 6, 18, 44, 46, 51 AND 52).
MICHAEL LITZAU, EXAMINING ATTORNEY
SN 79-111,705. ALMIRALL, S.A., SPAIN, FILED 2-20-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-7-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1112929
DATED 2-20-2012, EXPIRES 2-20-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR USE
IN THE TREATMENT OF RESPIRATORY DISEASES
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY
SN 79-111,706. ALMIRALL, S.A., SPAIN, FILED 2-20-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-7-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1112930
DATED 2-20-2012, EXPIRES 2-20-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR USE
IN THE TREATMENT OF RESPIRATORY DISEASES
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY
CLASS 5—(Continued).
SN 79-111,707. ALMIRALL, S.A., SPAIN, FILED 2-20-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-7-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1112931
DATED 2-20-2012, EXPIRES 2-20-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR USE
IN THE TREATMENT OF RESPIRATORY DISEASES
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY
SN 79-111,712. ALMIRALL, S.A., SPAIN, FILED 2-20-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-7-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1112936
DATED 2-20-2012, EXPIRES 2-20-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR USE
IN THE TREATMENT OF RESPIRATORY DISEASES
(U.S. CLS. 6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY
SN 79-112,655. ALMIRALL, S.A., SPAIN, FILED 2-29-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-22-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1115300
DATED 2-29-2012, EXPIRES 2-28-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF RESPIRATORY DISEASES (U.S. CLS.
6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY
SN 79-112,656. ALMIRALL, S.A., SPAIN, FILED 2-29-2012.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
PRIORITY DATE OF 2-22-2012 IS CLAIMED.
OWNER OF INTERNATIONAL REGISTRATION 1115301
DATED 2-29-2012, EXPIRES 2-28-2022.
FOR PHARMACEUTICAL PREPARATIONS FOR THE
TREATMENT OF RESPIRATORY DISEASES (U.S. CLS.
6, 18, 44, 46, 51 AND 52).
STEVEN JACKSON, EXAMINING ATTORNEY